This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as a Hybrid Event, March, 2022
Live In-Person: March 14-15 in Miami, FLDigital Experience: March 16-17

Joyce Hauze
Associate Director, Clinical Trial Disclosure and Transparency at Mallinckrodt Pharmaceuticals

Profile

Joyce Hauze is an ACRP-certified clinical research associate and project manager, with her bachelor’s in Experimental Psychology (Pharmacology), and graduate studies in Neuro-psychopharmacology.

During her 44-year career, she has:

  • served as facility manager for a PHS Small Business Innovation Research Grant to develop an antisense strategy to inhibit formation of 5HT2 receptors in the rat brain;
  • served as preclinical facility manager and principal investigator, then clinical study manager;
  • authored grant proposals, manuscripts, protocols, informed consent/assent documents, lay summary templates and guidelines, investigator brochures, clinical development plans, and clinical sections of INDs;
  • audited clinical study reports and trial master files; and
  • held increasingly responsible roles in intellectual property law, clinical operations, quality assurance, regulatory intelligence, and clinical trial disclosure and transparency.

Joyce currently is a member of the DIA Clinical Trial Disclosure Community and serves on the CDISC Protocol Entities Working Group.

Agenda Sessions

  • PANEL: EU Clinical Trial Regulations and Clinical Trials Information System (CTIS)

    8:30am
  • PANEL: Balancing Timely Disclosure, Meeting Regulations whilst Maintaining Trial Integrity

    4:15pm